glp 1 with hormone therapy Glucagon-like peptide-1 receptor: mechanisms and advances in Evolution of GLP‐1 Receptor Agonists

Description

The SMGT-GLP-1 Nano Microneedle Patch offers a long-lasting, slow release of the medication, ensuring a stable effect over 24 hours without causing any discomfort

The risk of comorbidities, including T2DM, cardiovascular disease, dyslipidemia, and atherosclerosis, is independently correlated with visceral fat mass that is inadequately distinguished by BMI or total body fat

Wegovy (Semaglutide)- a once-weekly subcutaneous injection given in the back of the arm, the thigh, or the abdomen

I would love some basic mitochondrial studies, especially given its results on HRV Great to see discussions around the benefits of GLP-1 beyond just weight loss

Activation of GLP-1R leads to an increase in intracellular cAMP and/or calcium, triggering signaling pathways including protein kinase A (PKA), exchange proteins directly activated by cAMP (Epac-2), phospholipase C (PLC), and extracellular signal-regulated kinase 1 and 2 (ERK1/2), thereby mediating effects on glycemic regulation, immune process, and inflammation